David R. Scott - Concepedia

Author

David R. Scott

National Cancer Institute

Also Known As

D R Scott, D. R. Scott, D.R. Scott, D. R. Scott, DAVID R. SCOTT, David R Scott, David R. Scott, David R. Scott

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Kaiser Permanente Center for Health Research Kaiser Permanente Division of Cancer Epidemiology and Genetics National Institutes of Health

About

David R. Scott is an author at National Cancer Institute specializing in medicine, human papillomavirus vaccines, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.8K
2	Public Health	9	9	1.7K
3	Epidemiology	4	4	1.3K
4	Biochemistry	1	1	116
5	Clinical Immunology	1	1	151

David R. Scott

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice Michelle J. Khan, Philip E. Castle, Attila T. Lörincz, JNCI Journal of the National Cancer Institute	2005	1K
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women Allan Hildesheim, Mark Schiffman, Patti E. Gravitt, The Journal of Infectious Diseases PathologyGynecologyHpv InfectionCytopathologyCarcinoma	1994	688
A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV Types Kai‐Li Liaw, Allan Hildesheim, Robert D. Burk, The Journal of Infectious Diseases Viral DiagnosticsPathologyGynecologyNucleic Acid Amplification TestReal-time Polymerase Chain Reaction	2001	297
Viral load of human papillomavirus and risk of CIN3 or cervical cancer Attila T. Lörincz, Philip E. Castle, Mark E. Sherman, The Lancet Viral LoadCervical Cancer ScreeningEpidemiologyCervical CancerCervical Health	2002	265
Determinants of Genital Human Papillomavirus Infection in Low-Risk Women in Portland, Oregon Heidi M. Bauer, Allan Hildesheim, Mark H. Schiffman, Sexually Transmitted Diseases	1993	236
Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand David R. Scott, Jeffrey K. W. Wong, Tim Spicer, Transplantation	2010	152
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Taku Tsukui, Allan Hildesheim, Mark H. Schiffman, PubMed Clinical ImmunologyInvasive Cervical CancerHpv-16 PeptidesHuman Papillomavirus-derived PeptidesImmunology	1996	151
A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study Mark Schiffman, Andrew G. Glass, Nicolas Wentzensen, Cancer Epidemiology Biomarkers & Prevention	2011	142
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture Mark Schiffman, Nancy B. Kiviat, Robert D. Burk, Journal of Clinical Microbiology Genetic TestingViral DiagnosticsInterlaboratory ReliabilityDna AnalysisDiagnosis	1995	138
Disruption of latent inhibition following systemic administration of parachlorophenylalanine (PCPA) Paul R. Solomon, Colleen A. Kiney, David R. Scott Physiology & Behavior Latent InhibitionBiochemistryMedicineToxicologyPharmacotherapy	1978	116

Page 1